Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

Resverlogix Corp > maybe something is up? IRAP/ISED & consultant update
View:
Post by general360 on May 16, 2022 12:54pm

maybe something is up? IRAP/ISED & consultant update

i still stand by my comments with the criminally stupid communications from the co.  leave MUCH to be desired.  but doing our own DD...i swear i get more info from these online anonymous bboards than i get from the company. their news releases always leave me w/ MORE questions than answers...

there were 2 more meetings held w/ our consulatant and the Director of IRAP/ISED.


someone over at agora posted this link a couple weeks back, i've been watching it.  we've progressed to meeting w/ some office assistants, to meeting w/ the director 3 x?

hmmmmmmmmmmmmmm

then we get comments about ending early to focus our limited resources....

link and shoutout to Jonzobot (maybe it was him/her/they who posted the link in the first place?). thanks to whomever posted this in the first place!

https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/vwRg?cno=368876&regId=909690&blnk=1

2 new reports filed yesteday/today for 2 new mtgs 4/11 and 4/22
  1. mtg 3/16 w/ assistants
  2. mtg 3/21 w/ Laurel Porth-Jones, Director General | IRAP | Innovation, Science and Economic Development Canada (ISED)
  3. mtg 4/11 w/ Laurel Porth-Jones, Director General | IRAP | Innovation, Science and Economic Development Canada (ISED)
  4. mtg 4/22 w/ Laurel Porth-Jones, Director General | IRAP | Innovation, Science and Economic Development Canada (ISED)

and then we drop our poorly worded NR about 3 weeks later, 5/9?  did the floor drop out from underneath us in 3 weeks?  or is something actually percolating here w/ IRAP/ISED?


1st new update:

Resverlogix Corporation
Consultant: Bilal Cheema
Designated Public Office Holders who participated in the communication:
  • Laurel Porth-Jones, Director General | IRAP | Innovation, Science and Economic Development Canada (ISED)

Subject Matter of the communication: Economic Development, Health, Science and Technology
Communication date: 2022-04-22
Posted date: 2022-05-15
Communication number: 368876-531955

2nd new update:
Consultant: Bilal Cheema

Designated Public Office Holders who participated in the communication:
  • Laural Porth-Jones, Director General | IRAP | Innovation, Science and Economic Development Canada (ISED)

Subject Matter of the communication: Health, Research and Development
Communication date: 2022-04-11
Posted date: 2022-05-16
Communication number: 368876-529291
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities